HC Wainwright Comments on ANI Pharmaceuticals, Inc.’s Q1 2024 Earnings (NASDAQ:ANIP)

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free Report) – Research analysts at HC Wainwright issued their Q1 2024 EPS estimates for shares of ANI Pharmaceuticals in a note issued to investors on Monday, March 4th. HC Wainwright analyst O. Livnat forecasts that the specialty pharmaceutical company will post earnings of $0.72 per share for the quarter. […]

Leave a Reply

Your email address will not be published.

Previous post Investors Buy High Volume of Robinhood Markets Call Options (NASDAQ:HOOD)
Next post Zacks Research Brokers Raise Earnings Estimates for Corcept Therapeutics Incorporated (NASDAQ:CORT)